Centene Corporation $CNC Shares Acquired by Sanctuary Advisors LLC

Sanctuary Advisors LLC boosted its holdings in shares of Centene Corporation (NYSE:CNC) by 27.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,694 shares of the company’s stock after purchasing an additional 17,356 shares during the period. Sanctuary Advisors LLC’s holdings in Centene were worth $3,321,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Addison Advisors LLC raised its holdings in shares of Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after acquiring an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of Centene during the third quarter valued at approximately $27,000. WPG Advisers LLC raised its holdings in shares of Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after acquiring an additional 282 shares during the period. Bogart Wealth LLC raised its holdings in shares of Centene by 11,011.1% during the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after acquiring an additional 991 shares during the period. Finally, Ameriflex Group Inc. increased its stake in Centene by 152.5% in the 3rd quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock valued at $36,000 after buying an additional 610 shares during the period. 93.63% of the stock is owned by institutional investors and hedge funds.

Centene Price Performance

NYSE CNC opened at $53.80 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.10 and a debt-to-equity ratio of 0.76. The company has a fifty day simple moving average of $38.91 and a 200 day simple moving average of $39.45. The company has a market cap of $26.46 billion, a P/E ratio of -4.09, a P/E/G ratio of 1.06 and a beta of 0.59. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $64.15.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $1.14. The business had revenue of $49.94 billion during the quarter, compared to the consensus estimate of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. Centene’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.90 EPS. On average, sell-side analysts predict that Centene Corporation will post 3.4 EPS for the current year.

Key Headlines Impacting Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Q1 earnings beat and upgraded outlook — Centene reported stronger-than-expected Q1 results and raised guidance, improving margin visibility and prompting optimism about 2026–2027 recovery prospects. Article Title
• Positive Sentiment: Truist reiterates/raises stance to Buy — Truist moved to a Buy rating with a higher $58 target after the earnings beat, signaling conviction among some buy‑side analysts. Article Title
• Positive Sentiment: Multiple upgrades/favorable analyst commentary — Bank of America upgraded CNC to Buy with a $60 target; Cantor Fitzgerald and other boutiques also raised ratings/targets after Q1. These calls support upside sentiment. Article Title
• Neutral Sentiment: UBS raised its price target to $55 but kept a Neutral rating — higher PTs broadly reflect improved forecasts, though many firms still rate CNC neutral/hold. Article Title
• Neutral Sentiment: Jefferies, Morgan Stanley, Mizuho, Deutsche Bank raised targets but maintained Hold/Equal Weight/Neutral ratings — these moves tighten analyst valuation ranges but leave consensus mixed on near‑term upside. Article Title Article Title Article Title Article Title
• Neutral Sentiment: Market commentary sees a potential momentum reversal into 2027 — bullish longer‑term narrative but recommends watching execution and margin trends. Article Title
• Negative Sentiment: Proposed Medicare Advantage reform (H.R. 8375) introduces transparency, real‑time auth and stricter oversight — if enacted, these changes could raise compliance/operational costs for MAOs like Centene and pressure margins over time. Legislative timing and details remain uncertain. Article Title

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CNC shares. Robert W. Baird upped their price objective on shares of Centene from $36.00 to $37.00 and gave the company a “neutral” rating in a research note on Wednesday, April 15th. Mizuho upped their price objective on shares of Centene from $41.00 to $50.00 and gave the company a “neutral” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Centene from $39.00 to $53.00 and gave the company a “hold” rating in a research note on Wednesday. Sanford C. Bernstein reiterated an “outperform” rating and issued a $59.00 price objective on shares of Centene in a research note on Tuesday, January 6th. Finally, Bank of America upgraded shares of Centene from an “underperform” rating to a “buy” rating and upped their price objective for the company from $34.00 to $60.00 in a research note on Wednesday. Six equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $51.41.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.